Literature DB >> 26993862

Aspiration thrombectomy using a large-size catheter for acute lower extremity deep vein thrombosis.

Zhongzhi Jia1, Jianfei Tu2, Jinwei Zhao1, Baosheng Ren1, Feng Tian1, Kai Wang1, Shaoqin Li1, Guomin Jiang3.   

Abstract

OBJECTIVE: This study retrospectively evaluated the safety and efficacy of aspiration thrombectomy using a large-size catheter for acute lower extremity deep vein thrombosis (DVT).
METHODS: All patients who underwent aspiration thrombectomy using 9F or 10F catheters for acute lower extremity DVT were included and analyzed. Aspiration thrombectomy was performed in all patients. Additional intravenous thrombolysis was performed in patients with residual thrombus, and stent placement was performed in patients with iliac vein compression syndrome.
RESULTS: From October 2010 to September 2013, the study enrolled 68 patients (37 women, 31 men) with a mean age of 61.7 ± 7.8 years (range, 24-86 years). All patients presented with lower extremity swelling and pain, and the duration of symptoms ranged from 1 to 14 days. The DVTs involved popliteal-iliofemoral veins in 29 patients, iliofemoral veins in 31, and iliac veins in 8. Endovascular procedures were performed in all patients with a technical success rate of 100%. Aspiration alone was effective in 47 patients, and additional thrombolysis was required in the remaining 21. An additional stent was required in 32 patients. Significant improvement in presenting symptoms was achieved in all patients after the procedures, with a clinical success rate of 100%. There were no procedure-related or thrombolysis-related complications. The Villalta scores were <5 in 60 patients and from 5 to 9 in four patients. Primary and secondary patency rates were 89.1% (57 of 64) and 96.9% (62 of 64) at 1 year of follow-up.
CONCLUSIONS: Aspiration thrombectomy using a large-size catheter is safe and effective for acute lower extremity DVT.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26993862     DOI: 10.1016/j.jvsv.2015.09.009

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  7 in total

Review 1.  Pharmacologic and Pharmacomechanical Thrombolysis for Acute Deep Vein Thrombosis: Focus on ATTRACT CME.

Authors:  Anthony J Comerota
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

2.  Downregulation of interleukin-6 and C-reactive protein underlies a novel inhibitory role of microRNA-136-5p in acute lower extremity deep vein thrombosis.

Authors:  Minghui Ou; Shaobo Hao; Jing Chen; Shibo Zhao; Shichao Cui; Jie Tu
Journal:  Aging (Albany NY)       Date:  2020-11-14       Impact factor: 5.682

3.  FXII regulates the formation of deep vein thrombosis via the PI3K/AKT signaling pathway in mice.

Authors:  Yan Meng; Qian Yin; Qiang Ma; Hao Qin; Junbo Zhang; Bo Zhang; Honggang Pang; Hongyan Tian
Journal:  Int J Mol Med       Date:  2021-03-24       Impact factor: 4.101

4.  In vitro investigation of a new thrombus aspiration and autologous blood reinfusion system.

Authors:  Weixiao Li; Qiang Li; Shuiting Zhai; Tianxiao Li; Nick Cheshire; Zhidong Zhang; Kai Liang
Journal:  J Interv Med       Date:  2019-06-27

5.  A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.

Authors:  Ghulam M Majeed; Krishan Lodhia; Jemima Carter; Jack Kingdon; Rachael I Morris; Adam Gwozdz; Athanasios Saratzis; Prakash Saha
Journal:  J Endovasc Ther       Date:  2021-11-10       Impact factor: 3.089

6.  Effect of miR-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1.

Authors:  Ke-Cheng Tang; Zhi-Peng Yang; Qiu Zeng; Jing Wang; Feng Guo; Yu Zhao
Journal:  Biosci Rep       Date:  2018-12-21       Impact factor: 3.976

7.  Application of manual aspiration thrombectomy in the treatment of deep vein thrombosis in cancer patients: Descriptive retrospective cohort study.

Authors:  Eu Hyun Kim; Hae Giu Lee; Jung Suk Oh; Ho Jong Chun; Byung Gil Choi; Myung Ah Lee
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.